Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Evommune (EVMN) Accumulated Depreciation & Amortization (2024 - 2025)

Evommune (EVMN) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $600000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 20.0% to $600000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $600000.0, a 20.0% increase, with the full-year FY2025 number at $600000.0, up 20.0% from a year prior.
  • Accumulated Depreciation & Amortization was $600000.0 for Q4 2025 at Evommune, up from $500000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $600000.0 in Q4 2025 to a low of $500000.0 in Q4 2024.